Gallium Indium Metal Complex Radiolabelling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for 18F radiolabelling of biological molecules, such as peptides, face challenges due to hydrogen bonding interactions with amino acids like lysine and arginine, which reduce nucleophilicity and require higher temperatures, causing degradation or structural disruption, and are not suitable for aqueous conditions, limiting their applicability and efficiency.

Innovation Solution

A method for radiolabelling using gallium and indium metal complexes, which form stable fluoride bonds at room temperature and in aqueous conditions, allowing for high affinity fluoride binding and conjugation to biological molecules, enabling efficient 18F labelling under mild conditions without the need for organic solvents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If standard nucleophilic substitution methods are used to label biological molecules with 18F, then the labeling can be achieved, but the hydrogen bonding interactions with amino acids reduce nucleophilicity and require higher temperatures causing degradation

Engineering Contradiction:
Improvelabeling efficiencyVSAvoidreaction temperature
Core Design Contradiction:
ReliabilityVSTemperature

Solution Approach 1:

The patent introduces a metal complex (such as aluminum, gallium, indium, lutetium, or thallium) as an intermediary carrier that binds to the biological molecule and facilitates 18F incorporation. The metal complex acts as a mediator between the 18F fluoride source and the biological molecule, enabling labeling under mild conditions without direct nucleophilic attack on the amino acid residues.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the labeling system by introducing metal complexes with specific coordination chemistries. This allows the reaction to proceed at lower temperatures (room temperature to moderate heating) rather than requiring high temperatures, thereby avoiding peptide degradation while maintaining labeling efficiency.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If higher temperatures are used to overcome hydrogen bonding interactions, then nucleophilicity is improved, but peptide or protein structure is degraded or disrupted

Engineering Contradiction:
Improvenucleophilicity of fluorideVSAvoidpeptide/protein structure
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The metal complex serves as an intermediary that enhances fluoride nucleophilicity without requiring high temperatures. The metal center coordinates with fluoride and facilitates its transfer to the biological molecule through a mechanism that preserves peptide structure, avoiding thermal degradation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the thermal activation mechanism (heating to increase nucleophilicity) with a chemical mechanism involving metal complex coordination. This substitution allows fluoride activation without the mechanical/thermal stress that would disrupt peptide hydrogen bonding and overall structure.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If traditional radiolabelling methods are used, then labeling can be achieved, but the process requires organic solvents and multiple steps increasing complexity and time

Engineering Contradiction:
Improvelabeling capabilityVSAvoidradiolabelling process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The metal complex serves multiple functions simultaneously: it acts as a carrier for the biological molecule, provides a coordination site for fluoride binding, and facilitates the transfer of 18F to the molecule. This multi-functionality reduces the need for separate reagents and steps, simplifying the overall radiolabelling process.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent changes the solvent system parameter by enabling the reaction to proceed in aqueous or mixed aqueous-organic conditions rather than requiring purely organic solvents. This allows for simpler workup procedures and reduces the number of purification steps needed.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If conventional methods are used for 18F labelling, then labeling can be performed, but radioactive decay causes yield loss over time

Engineering Contradiction:
Improvelabeling achievementVSAvoidyield loss due to radioactive decay
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent replaces multi-step sequential operations with a more direct one-pot or near-one-pot procedure. By combining the metal complex formation, fluoride binding, and transfer steps into a single operational sequence, the time window for radioactive decay is minimized, thereby reducing yield loss.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for efficient 18F radiolabelling of peptides and other biological molecules at room temperature and in aqueous conditions, ensuring high in vivo stability and reducing the complexity and time of the radiolabelling process, thereby minimizing yield loss due to radioactive decay.

Implementation Method 1

gallium and indium metal complexes, which form stable fluoride bonds at room temperature and in aqueous conditions, allowing for high affinity fluoride binding

Methodology Applied
Scientific EffectCoordination chemistry: Chemical Bonding

Implementation Method 2

reacting the 18F with a metal to form an 18F metal complex; and attaching the 18F metal complex to a molecule

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Data Source

PatentUS11135322B2Radiofluorination method
Publication Date: 2021.10.05 GE HEALTHCARE LTD
  • US11135322B2 patent drawing
  • US11135322B2 patent drawing
  • US11135322B2 patent drawing

AI summary

The present invention relates to a method of labelling biological molecules with 18F, via attachment to fluorine to a macrocyclic metal complex of a non-radioactive metal, where the metal complex is conjugated to the biological molecule. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.